A.R.T. Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-31,098
Closed -$804K 1601
2019
Q3
$804K Sell
31,098
-54,902
-64% -$1.39M 0.04% 646
2019
Q2
$2.19M Buy
86,000
+8,200
+11% +$203K 0.12% 216
2019
Q1
$2.04M Sell
77,800
-30,000
-28% -$737K 0.12% 225
2018
Q4
$2.48M Sell
107,800
-23,600
-18% -$524K 0.16% 175
2018
Q3
$3.1M Buy
131,400
+16,000
+14% +$390K 0.14% 194
2018
Q2
$2.66M Buy
115,400
+83,800
+265% +$1.99M 0.11% 268
2018
Q1
$778K Buy
+31,600
New +$830K 0.03% 756
2017
Q4
Sell
-156,000
Closed -$3.75M 1579
2017
Q3
$3.75M Buy
156,000
+57,400
+58% +$1.3M 0.19% 124
2017
Q2
$2.11M Buy
98,600
+16,200
+20% +$327K 0.11% 256
2017
Q1
$1.41M Buy
+82,400
New +$1.43M 0.07% 433
2016
Q4
Sell
-39,400
Closed -$819K 1371
2016
Q3
$819K Buy
+39,400
New +$977K 0.26% 93
2015
Q3
Sell
-26,370
Closed -$722K 1515
2015
Q2
$722K Sell
26,370
-59,364
-69% -$1.67M 0.02% 846
2015
Q1
$2.29M Buy
85,734
+47,782
+126% +$1.1M 0.08% 343
2014
Q4
$803K Buy
+37,952
New +$848K 0.03% 746
2014
Q3
Sell
-35,694
Closed -$824K 1458
2014
Q2
$824K Buy
+35,694
New +$788K 0.04% 564
2013
Q4
Sell
-92,230
Closed -$1.56M 1436
2013
Q3
$1.56M Sell
92,230
-294,770
-76% -$4.96M 0.09% 347
2013
Q2
$6M Buy
+387,000
New +$6.44M 0.2% 147

Other funds holding NVO

A.R.T. Advisors's NVO Position: Q4 2019 in Review

A.R.T. Advisors sold out of Novo Nordisk (NVO) in Q4 2019, closing a stake of 31,098 shares — an estimated $804K sold.

A.R.T. Advisors first reported a position in NVO in Q2 2013 and held it in 17 quarters. The position peaked at $6M in Q2 2013. 640 funds tracked by Wall St. Rank hold NVO as of Q4 2019.

  • A.R.T. Advisors reported no remaining Novo Nordisk position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 31,098 Novo Nordisk shares in Q4 2019, an estimated $804K.
  • A.R.T. Advisors first reported a position in Novo Nordisk in Q2 2013 and held it in 17 quarters.
  • A.R.T. Advisors's Novo Nordisk position peaked at $6M in Q2 2013.
  • 640 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.